Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Roland Grenningloh|The Journal of Immunology|2019Cited by 145
Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical StudiesPhilipp Haselmayer, Hong Ji|Frontiers in Immunology|2014Cited by 38